United Therapeutics Balance Sheet Health
Financial Health criteria checks 5/6
United Therapeutics has a total shareholder equity of $6.0B and total debt of $700.0M, which brings its debt-to-equity ratio to 11.7%. Its total assets and total liabilities are $7.2B and $1.2B respectively. United Therapeutics's EBIT is $1.2B making its interest coverage ratio -11.5. It has cash and short-term investments of $3.0B.
Key information
11.7%
Debt to equity ratio
US$700.00m
Debt
Interest coverage ratio | -11.5x |
Cash | US$2.99b |
Equity | US$5.98b |
Total liabilities | US$1.18b |
Total assets | US$7.17b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: UTH's short term assets ($3.6B) exceed its short term liabilities ($804.4M).
Long Term Liabilities: UTH's short term assets ($3.6B) exceed its long term liabilities ($377.8M).
Debt to Equity History and Analysis
Debt Level: UTH has more cash than its total debt.
Reducing Debt: UTH's debt to equity ratio has increased from 9% to 11.7% over the past 5 years.
Debt Coverage: UTH's debt is well covered by operating cash flow (139.7%).
Interest Coverage: UTH earns more interest than it pays, so coverage of interest payments is not a concern.